Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13

Cannabidiol, a compound of Cannabis sativa, has been proposed as an alternative treatment of schizophrenia. Preclinical and clinical data have suggested that cannabidiol shares more similarity with atypical antipsychotics than typical, both of which are customarily used to manage schizophrenia sympt...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Mol Neurosci
Autori principali: Falvella, Ana Caroline Brambilla, Smith, Bradley Joseph, Silva-Costa, Licia C., Valença, Aline G. F., Crunfli, Fernanda, Zuardi, Antonio W., Hallak, Jaime E., Crippa, José A., de Almeida, Valéria, Martins-de-Souza, Daniel
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Molecular Neuroscience
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8193732/
https://ncbi.nlm.nih.gov/pubmed/34122009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnmol.2021.673144
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi